Negative regulation of ceramide biosynthetic process

pathway activity — cross-omics
GO:1900060Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of ceramide biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CLPB, EVA1C, and CHIT1, each associated with the pathway in up to 3 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of ceramide biosynthetic process activity versus CLPB in LSCC (Pearson r = -0.33).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCCLPB →-0.496-0.635.003.00233
GBMEVA1C →+0.587+0.216.004<.00133
LUADCHIT1 →+0.823+0.394.005.00233
PDACNPHS1 →-0.643-0.452.001.00332
PDACCTRC →-3.646-0.360<.001.00732
PDACONECUT1 →-0.848-0.321.001.00132
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1900060 vs CLPB — LSCC

Per-sample scatter of Negative regulation of ceramide biosynthetic process activity vs CLPB in LSCC.

Explore this scatter interactively →

Exploration